Menu Search
Equities

Olaplex Holdings Inc

OLPX:NSQ

Olaplex Holdings Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)2.38
  • Today's Change-0.04 / -1.65%
  • Shares traded1.82m
  • 1 Year change+5.31%
  • Beta--
Data delayed at least 15 minutes, as of Sep 16 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold9
Sell1
Strong Sell0

Share price forecast in USD

The 9 analysts offering 12 month price targets for Olaplex Holdings Inc have a median target of 2.00, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a -15.97% decrease from the last price of 2.38.
High110.1%5.00
Med-16.0%2.00
Low-16.0%2.00

Earnings history & estimates in USD

On Aug 06, 2024, Olaplex Holdings Inc reported 2nd quarter 2024 earnings of 0.03 per share. This result was in line with the consensus of the 11 analysts following the company and was the same as last year's 2nd quarter results.
The next earnings announcement is expected on Nov 08, 2024.
Average growth rate+6.67%
Olaplex Holdings Inc reported annual 2023 earnings of 0.16 per share on Feb 29, 2024.
Average growth rate-25.97%
More ▼

Revenue history & estimates in USD

Olaplex Holdings Inc had 2nd quarter 2024 revenues of 103.94m. This bettered the 103.65m consensus of the 8 analysts covering the company. This was 8.65% below the prior year's 2nd quarter results.
Average growth rate-0.71%
Olaplex Holdings Inc had revenues for the full year 2023 of 458.30m. This was 34.93% below the prior year's results.
Average growth rate-8.61%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.